Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control Study
Basic & Clinical Pharmacology & Toxicology · 2026-06 · 138 (6)
DOI: 10.1111/bcpt.70249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 21.05.2026. Verfasst von Barkat Babar und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Furosemide, Parkinson Disease, Diuretics. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Michael J. Fox Foundation, Kuopio University Foundation, Orion Pharma Foundation.
Abstract (Originalsprache)
A French signal detection study identified an association between sulfonamide diuretics use, particularly furosemide, and lower Parkinson's disease (PD) risk. Our aim was to confirm this association in a Finnish nationwide nested case–control study (FINPARK), primarily in an indication‐restricted case–control study of persons with heart or renal failure. Altogether 19 568 PD cases diagnosed in 1999–2015 and 130 156 age, sex and region‐matched controls were included. The case–control study restricted to those with heart or renal failure included 1222 PD cases and 4766 matched controls. Furosemide use was identified from Prescription Register (1995–2015). The main analysis considered exposure at least 3 years before the matching date (3‐year lag). Additional analyses with no lag, 5‐ and 8‐year lags were conducted. Furosemide was not associated with PD risk (adjusted OR, 95% CI 1.00, 0.87–1.15 for user–non‐user comparison with 3‐year lag). A statistically significant borderline association between higher exposure levels and lower PD risk was observed in comparing risk across categories of cumulative furosemide exposure (adjusted OR, 95% CI 0.80, 0.64–1.00 with 3‐year lag). Our nationwide indication‐restricted case–control study of persons with PD found no robust evidence on the association between furosemide use and PD risk. However, there was suggestive evidence of reduced risk for participants in the highest exposure category.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
- Kuopio Research Center of Geriatric Care, University of Eastern Finland, Kuopio, Finland.
- Université Paris-Saclay, UVSQ, Inserm CESP, High-Dimensional Biostatistics for Drug Safety and Genomics, Villejuif, France.
- Department of Public Health, Finnish National Institute for Health and Welfare (THL), Helsinki, Finland.
- Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Exposome and Heredity, Villejuif, France.
ORCID-Profile: Barkat Babar, Anne Paakinaho, Emeline Courtois, Alexis Elbaz, Anne C M Thiébaut, Miia Tiihonen, Anna-Maija Tolppanen
Förderung
- Michael J. Fox Foundation
- Kuopio University Foundation
- Orion Pharma Foundation
- Pävikki and Sakari Sohlbergin Foundation
- Finnish Cultural Foundation
- Michael J. Fox Foundation for Parkinson's Research
- Suomen Kulttuurirahasto
Zitieren
APA
Babar, B., Paakinaho, A., Courtois, E., Rumrich, I., Saidi, Y., Elbaz, A., Thiébaut, A. C. M., Ahmed, I., Tiihonen, M., Hartikainen, S., & Tolppanen, A. M. (2026). Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control Study. Basic & Clinical Pharmacology & Toxicology, 138(6). https://doi.org/10.1111/bcpt.70249
Vancouver
Babar B, Paakinaho A, Courtois E, Rumrich I, Saidi Y, Elbaz A, et al. Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control Study. Basic & Clinical Pharmacology & Toxicology. 2026;138(6). doi:10.1111/bcpt.70249
BibTeX
@article{Babar2026,
author = {Babar, Barkat and Paakinaho, Anne and Courtois, Emeline and Rumrich, Isabell and Saidi, Yanis and Elbaz, Alexis and Thiébaut, Anne C M and Ahmed, Ismaïl and Tiihonen, Miia and Hartikainen, Sirpa and Tolppanen, Anna-Maija},
title = {Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control Study},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {138},
number = {6},
doi = {10.1111/bcpt.70249}
}
EUVIMED